Nearly 600 postmarket studies the FDA required drugmakers and devicemakers to complete after approving their products are behind schedule, according to a Sept. 18 KFF Health News analysis. Some are ...

Silver Spring, MD, Sept. 15, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot. Accelerating ...

Hearing examines training, screening, reimbursement, clinic capacity and long-term safety tracking Experts seek clear guardrails on safety and patient access Safety and efficacy must underpin any ...

All proposals must be submitted in accordance with the requirements specified in the funding opportunity and in the Proposal & Award Policies & Procedures Guide (PAPPG) and its supplements. All NSF ...

The US Food and Drug Administration (FDA) has issued an alert over Boston Scientific's recall of a lead kit used with its spinal cord stimulator (SCS) system at a time when the company and other ...

Please provide your email address to receive an email when new articles are posted on . The FDA recommends phosphate monitoring for patients at risk for hypophosphatemia or receiving repeat therapy.

The US Food and Drug Administration has signed off on updated Covid-19 vaccines for many Americans. Pfizer and BioNTech said Thursday that the agency had approved their mRNA-based Covid shot for all ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The U.S. Food and Drug Administration approved the use of a new cancer treatment pill Wednesday. Rasonque, manufactured by Revolution Medicines in California, is an inhibitor for the most common type ...

For four decades, cancer researchers fought to disable a stubborn mutation that made pancreatic cancer a death sentence—to little avail. Now, doctors have a medicine that targets the mutation. The ...

The US Food and Drug Administration announced Wednesday it has approved a groundbreaking treatment option for pancreatic cancer. Manufactured by Revolution Medicines, daraxonrasib made headlines ...

A sign for the Food And Drug Administration is seen outside of the headquarters in White Oak, Maryland. The medication, made by the biotech company Revolution Medicines and sold under the brand name ...